Insider · CIK 0001692359
Richard Brudnick
Files at SRRK (Scholar Rock Holding Corp), PRME (Prime Medicine, Inc.). First filing May 22, 2025, latest May 30, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SRRK: Scholar Rock Holding Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 32Weak | Scholar Rock Holding Corp | $181k 6,075 shares | -29% | +322% from low-36% from high | |
| 38Weak | Prime Medicine, Inc. | $24k 20,000 shares | - | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 29, 2025 | SRRK Scholar Rock Holding Corp | SOpen-market sale Common Stock10b5-1 | -4,675 | $29.63 | $139k | 16,457 | May 30, 2025 |
| May 29, 2025 | SRRK Scholar Rock Holding Corp | SOpen-market sale Common Stock10b5-1 | -1,400 | $30.00 | $42k | 15,057 | May 30, 2025 |
| May 22, 2025 | SRRK Scholar Rock Holding Corp | AGrant or award Common Stock | +7,632 | $0.00 | $0 | 21,132 | May 23, 2025 |
| May 22, 2025 | SRRK Scholar Rock Holding Corp | AGrant or award Stock Option (Right to Buy)derivative | +9,206 | $0.00 | $0 | 9,206 | May 23, 2025 |
| May 20, 2025 | PRME Prime Medicine, Inc. | POpen-market purchase Common Stock | +20,000 | $1.19 | $24k | 20,000 | May 22, 2025 |
| Feb 27, 2025 | PRME Prime Medicine, Inc. | AGrant or award Stock Option (right to buy)derivative | +225,000 | $0.00 | $0 | 225,000 | Mar 3, 2025 |
| Dec 5, 2024 | PRME Prime Medicine, Inc. | AGrant or award Stock Option (right to buy)derivative | +19,300 | $0.00 | $0 | 57,900 | Dec 9, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.